Media Tip Sheet: FDA Approves First Treatment for Severe Frostbite

GW expert available to speak to the media regarding the new treatment

February 16, 2024

Frost patterned window

Iloprost injection, marketed under the brand name Aurlumyn, is a vasodilator, a drug that opens blood vessels and prevents blood clotting.

Frostbite happens when skin and underlying tissues freeze, limiting blood flow to the area. Early symptoms include skin redness and pain, followed by numbness and white or grayish-yellow skin discoloration, according to the CDC.

Andriana Glenn, an assistant professor in The George Washington University School of Nursing, is available to talk about this new development and how this is a major step forward in frostbite treatment in the U.S.

If you would like to schedule an interview, please contact Katelyn Deckelbaum, katelyn [dot] deckelbaumatgwu [dot] edu (katelyn[dot]deckelbaum[at]gwu[dot]edu).

-GW-